… for patients with pancreatic cancer is poor, even after resection with curative intent.
Gemcitabine-based chemotherapy is standard treatment for advanced pancreatic cancer, but its …

… An IRB-approved pancreatic cancer database was queried for patients with upfront resected
pancreatic head cancer treated at our institution between 2000 and 2012. Overall survival (…

… When analysing a resection specimen from a patient with pancreatic ductal adenocarcinoma,
there are several key features that must be documented in the pathology report. Like many …

… immunohistochemical markers in resected pancreatic cancer is variably reported. The … (EGFR)
expression as prognostic factors in resected pancreatic adenocarcinoma and to conduct a …

… with pancreatic cancer even after complete surgical resection strongly … resections develop
liver metastases, with no evidence of local recurrence. This suggests that in pancreatic cancer, …

Background The 1-year disease-related mortality after resection for pancreatic cancer is
approximately 30%. This study examined potential preoperative parameters that would help …

… Survival is better for those with malignant disease localised to the pancreas, because
surgical resection at present offers the only chance of cure. Unfortunately, 80–85% of patients …

… We found that DFS in patients with resected pancreatic cancer was significantly improved …
surgery-only after macroscopically curative resection of pancreatic cancer. Table 5 shows a …

… A prospectively maintained pancreatic cancer database was reviewed, and 696 consecutive
patients were identified who underwent resection for pancreatic adenocarcinoma between …

Purpose: In research settings, circulating tumor DNA (ctDNA) shows promise as a tumor-specific
biomarker for pancreatic ductal adenocarcinoma (PDAC). This study aims to perform …